Results 271 to 280 of about 41,675 (347)

RETHINKING RIGHT VENTRICULAR SHOCK: RIGHT VENTRICULAR ASSIST DEVICE AS A BAILOUT STRATEGY IN CARDIOGENIC SHOCK AFTER RIGHT VENTRICLE INFARCTION

Devin Stives, Renuka Jain, Andrew A. Lin, Jayant Khitha   +3 more
openalex   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source

Left ventricular assist device implantation and surgical repair in advanced congenitally corrected transposition of the great arteries. [PDF]

Eur Heart J Case Rep
Xie W, Ge Y, Cao H.
europepmc   +1 more source

Outcomes in Patients Requiring VENO‐Venous Extracorporeal Membrane Oxygenation After Cardiac Surgery: An Analysis From the PELS‐1 Study

Artificial Organs, EarlyView.
We report an insight from the PELS‐1– a multicentre, international registry focusing on postocardiotomy extracorporeal support use between 2000 and 2020. We focused on 24/2163 (1.1%) patients requiring V‐V ECMO after cardiac surgery. Mortality was high, with 21.7% of patients discharged alive and an overall 1‐year survival probability of 12.5 ...
Pasquale Nardelli, Silvia Mariani, Maria Elena De Piero, Bas C. T. van Bussel, Michele Di Mauro, Ann‐Kristin Schaefer, Diyar Saeed, Matteo Pozzi, Luca Botta, Udo Boeken, Robertas Samalavicius, Karl Bounader, Xiaotong Hou, Jeroen J. H. Bunge, Hergen Buscher, Leonardo Salazar, Bart Meyns, Michael A. Mazzeffi, Marco L. Sacha Matteucci, Sandro Sponga, Kollengode Ramanathan, Claudio Russo, Francesco Formica, Pranya Sakiyalak, Antonio Fiore, Daniele Camboni, Giuseppe Maria Raffa, Rodrigo Diaz, I‐wen Wang, Jae‐Seung Jung, Jan Belohlavek, Vin Pellegrino, Giacomo Bianchi, Matteo Pettinari, Alessandro Barbone, José P. Garcia, Kiran Shekar, Glenn Whitman, Roberto Lorusso, PELS Investigators   +39 more
wiley   +1 more source

Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF‐LVADs?

Artificial Organs, EarlyView.
Gastrointestinal bleeding significantly increases thromboembolic risk. Higher risk was also seen in patients aged ≥ 50 years, Black patients, and those with older CF‐LVAD models. ABSTRACT Background Gastrointestinal bleeding is a common complication in continuous‐flow left ventricular assist device (CF‐LVAD) patients. Managing gastrointestinal bleeding
Anh Nguyen, Alexis Shafii, Gabriel Loor, Subhasis Chatterjee, Andrew Civitello, O. Howard Frazier, Kenneth Liao   +6 more
wiley   +1 more source

Safety of extensive pulsed field ablation for atrial fibrillation in a patient with left ventricular assist device: a case report. [PDF]

Eur Heart J Case Rep
Ouali S, Jebberi Z, Sebki D, Ben Halima M, Mourali MS.   +4 more
europepmc   +1 more source

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev, Wilson Agyapong, Bjarne Jürgens, Elisa Mohr, Shambhabi Chatterjee, Hannah J. Hunkler, Jawad Salman, Giuseppe Cipriano, Marco Bentele, Junqing Liu, Jonas Specht, Kaja S. Menge, Florian J. G. Waleczek, Jonas A. Haas, Anselm A. Derda, Kristina Sonnenschein, Anika Gietz, Susanne Neumüller, Angelika Pfanne, Oliver Beetz, Michael Pflaum, Bettina Wiegmann, Yiangos Psaras, Christopher Toepfer, Robert Zweigerdt, Ante Radocaj, Theresia Kraft, Andre Zeug, Evgeni Ponimaskin, Wilhelm Korte, Alexander Horke, Arjang Ruhparwar, Maximilian Fuchs, Ke Xiao, Christian Bär, Natalie Weber, Thomas Thum   +36 more
wiley   +1 more source

Perioperative management of non-cardiac surgery in patients on long-term left ventricular assist device support. [PDF]

Turk Gogus Kalp Damar Cerrahisi Derg
Kilercik H, Balkanay M, Doğan A, Konukoğlu O, Sever K, Mansuroğlu D.   +5 more
europepmc   +1 more source

Mitochondrial Ca2+ overload is a pivotal risk factor for lethal ventricular arrhythmias due to the oxidation of mitochondrial respirasome and energetic failure

British Journal of Pharmacology, EarlyView.
The data that support the findings of this study are available from the corresponding author upon reasonable request. Some data may not be made available because of privacy or ethical restrictions. Background and Purpose Ventricular arrhythmias are a leading cause of death among patients with cardiovascular diseases and are associated with elevated ...
Felipe de Jesús Salazar‐Ramírez, Luis Alberto Luévano‐Martínez, Abraham Méndez‐Fernández, Judith Bernal‐Ramírez, Carolina A. Morales‐Ochoa, Christian Silva‐Platas, Alfredo Cabrera‐Orefice, Ana C. Murrieta, José Luis Velasco‐Bolom, Gricelda Mendiola‐Garza, Flavio Contreras‐Torres, Guillermo Torre‐Amione, Ernesto A. Aiello, Gerardo García‐Rivas   +13 more
wiley   +1 more source

Long-Term Implantable Biventricular Assist Device Support　- Experience of 6 Cases. [PDF]

Circ Rep
Imaoka S, Saito S, Yoshioka D, Kawamura T, Kawamura A, Yajima S, Matsuura R, Misumi Y, Miyagawa S.   +8 more
europepmc   +1 more source